Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Just rather not listen to your BS Novice that’s all. I’d rather just wait and see the outcome and not read your rubbish
Roobler, he’s probably only got a couple of hundred quid in it. He’s probably not bothered if it comes back or not and just trying wind people up. Ignore him, talks nonsense
Clicked on wrong share chat lol. As much as I want this to come back not just my sake, everyone’s. I personally think it’s done with
Email -
I can not add anything further to what was announced on the 29 July 2020.
Motif Bio shares have been suspended. Trading will remain suspended until the completion of a Reverse Takeover, or the Company is re-admitted to trading on AIM as an investing company. The Company has six months to do so and the Board stated in the RNS that it continues to evaluate potential Reverse Takeover candidates and will make a further announcement at the appropriate time
How many bust?
I know this might sound negative, but I can’t see anything coming of it. I hope I’m wrong for everyone’s sake including mine
Good Afternoon,
Thank you for your email.
Motif Bio shares have been suspended which means you are unable to trade them. Trading will remain suspended until the completion of a Reverse Takeover, or the Company is re-admitted to trading on AIM as an investing company. The Company has six months to do so and the Board stated in the RNS yesterday that it continues to evaluate potential Reverse Takeover candidates and will make a further announcement at the appropriate time. If no such transaction is completed within six months the Company's shares will be cancelled from trading on AIM pursuant to AIM Rule 41. There can be no assurance that the Company will be able to complete a Reverse Takeover during the six month suspension period.
Would you like to be added to the Motif Bio distribution list? This will mean you’ll receive all future, relevant investor communications going forward?
Kind regards,
Lianne
Lianne Cawthorne
Associate Director
Fingers crossed we don’t see you Monday Bobby, but I guess that’s wishful thinking. Hopefully you may find interest somewhere else or maybe somewhere you’re actually invested
Exactly Private dofus, they don’t want to miss out before suspension
A sign that something is happening
Bobby, well aware Peel Hunt don’t have any shares, but recently appointed as strategic adviser to the RTO..
Mark - all Sounds positive to me.
Bobby and co answer me this, They wouldn’t of raised money, they wouldn’t of delayed financials, they wouldn’t of advised they was looking at multiple candidates and they wouldn’t of brought Peel Hunt in just for it to delist.. what would be the point?
A lot of panic selling today
That what he’s just posted is news previous to what I’ve just posted. He’s a moron
I know this has already been discussed but just for Blobby
Jonathan Gold, Motif Bio's president and chief business officer, said: "Following the recent fundraise we are pleased to be in a position where we have several options to evaluate. We are currently working with our advisers to identify the most appropriate reverse takeover candidate for the company and look forward to providing our shareholders with further updates as appropriate."
Sounds positive to me.. I’m holding into suspension
Motif Bio plc quote was equal to 0.460 at 2020-07-19. Based on our forecasts, a long-term increase is expected following RTO, the "MTFB" stock price prognosis for 2025-07-02 is 6.893 With a 5-year investment, the revenue is expected to be around +1398.52%
2x 1 million look likes buys to me blobby
There’s literally nothing to worry about. It’s just going to keep fluctuating between 0.44 and yesterday’s price until the last day where there will be an announcement of an RTO or suspension. If it goes down the suspension route I’d give it a month and there will be announcement.
Forget Blobby Bobby and his crownies
Iclaprim has received Qualified Infectious Disease Product (QIDP) designation from the FDA together with Fast Track status. Upon acceptance by the FDA of an NDA, iclaprim will receive Priority Review status and, if approved as a New Chemical Entity, will be eligible for 10 years of market exclusivity in the U.S. from the date of first approval, under the Generating Antibiotic Incentives Now Act (the GAIN Act). In Europe, 10 years of market exclusivity is anticipated.